Emflaza (Deflazacort Tablets) and Recombinate recombinant
Determining the interaction of Emflaza (Deflazacort Tablets) and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deflazacort
Brand name: Emflaza
Synonyms: Emflaza
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emflaza (Deflazacort Tablets)-Recombivax
- Emflaza (Deflazacort Tablets)-Recombivax HB
- Emflaza (Deflazacort Tablets)-Recombivax HB Adult
- Emflaza (Deflazacort Tablets)-Recombivax HB Dialysis Formulation
- Emflaza (Deflazacort Tablets)-Recombivax HB Pediatric/Adolescent
- Emflaza (Deflazacort Tablets)-Recort Plus
- Recombinate recombinant-Emicizumab
- Recombinate recombinant-Emicizumab-kxwh
- Recombinate recombinant-Emicizumab-kxwh Subcutaneous
- Recombinate recombinant-Emla
- Recombinate recombinant-Emla Topical
- Recombinate recombinant-Emo-Cort Scalp Solution Topical application